Envestnet Asset Management Inc. Purchases 13,504 Shares of Colgate-Palmolive (CL)

Envestnet Asset Management Inc. raised its position in Colgate-Palmolive (NYSE:CL) by 4.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 325,406 shares of the company’s stock after buying an additional 13,504 shares during the period. Envestnet Asset Management Inc.’s holdings in Colgate-Palmolive were worth $24,551,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CL. Virtue Capital Management LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $104,000. Jacobi Capital Management LLC boosted its position in shares of Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares during the last quarter. Krilogy Financial LLC boosted its position in shares of Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the last quarter. Calton & Associates Inc. bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $126,000. Finally, Cerebellum GP LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $129,000. Hedge funds and other institutional investors own 73.64% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other Colgate-Palmolive news, CFO Dennis J. Hickey sold 5,651 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $70.18, for a total value of $396,587.18. Following the sale, the chief financial officer now owns 413,221 shares of the company’s stock, valued at approximately $28,999,849.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 902 shares of Colgate-Palmolive stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the completion of the sale, the insider now directly owns 37,788 shares in the company, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 455,707 shares of company stock worth $32,443,427. Corporate insiders own 1.02% of the company’s stock.

Several research firms have recently issued reports on CL. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $84.00 price target on the stock in a research report on Monday, January 8th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a research report on Tuesday, December 19th. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Citigroup raised their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. Finally, Deutsche Bank began coverage on Colgate-Palmolive in a research report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price target on the stock. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $77.76.

Colgate-Palmolive stock opened at $68.38 on Friday. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The firm has a market capitalization of $59,854.86, a PE ratio of 23.83, a price-to-earnings-growth ratio of 2.53 and a beta of 0.79. Colgate-Palmolive has a twelve month low of $68.19 and a twelve month high of $77.91.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.75. The firm had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.75 earnings per share. equities analysts predict that Colgate-Palmolive will post 3.18 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be issued a dividend of $0.42 per share. The ex-dividend date is Thursday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a yield of 2.46%. Colgate-Palmolive’s payout ratio is currently 70.18%.

WARNING: “Envestnet Asset Management Inc. Purchases 13,504 Shares of Colgate-Palmolive (CL)” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3298474/envestnet-asset-management-inc-purchases-13504-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Astro 24-Hour Volume Reaches $3,638.00
Astro 24-Hour Volume Reaches $3,638.00
SyncFab Hits One Day Trading Volume of $45,979.00
SyncFab Hits One Day Trading Volume of $45,979.00
Microsoft Co.  Expected to Post Quarterly Sales of $25.71 Billion
Microsoft Co. Expected to Post Quarterly Sales of $25.71 Billion
Zacks: Analysts Anticipate Shutterstock  Will Announce Quarterly Sales of $150.17 Million
Zacks: Analysts Anticipate Shutterstock Will Announce Quarterly Sales of $150.17 Million
$8.32 Billion in Sales Expected for Enterprise Products  This Quarter
$8.32 Billion in Sales Expected for Enterprise Products This Quarter
Akamai Technologies  Expected to Post Quarterly Sales of $654.02 Million
Akamai Technologies Expected to Post Quarterly Sales of $654.02 Million


© 2006-2018 Ticker Report. Google+.